Results and presentations


Latest results announcements and presentations


2018


Year-end webcast for investors and analysts on China and Emerging Markets

13 December 2018


AHA Scientific Sessions 2018

12 November 2018


Year-To-Date and Q3 2018 Results

8 November 2018


General Investor Presentation

21 September 2018


H1 2018 Results

26 July 2018


AstraZeneca Investor Event at the 2018 ASCO Annual Meeting

1 June 2018


Q1 2018 Results

18 May 2018


Full-Year 2017 Results

2 February 2018


2017


Investor science event: Late-stage pipeline webcast

14 December 2017


Year-To-Date and Q3 2017 Results

9 November 2017


AstraZeneca Investor Science Event at ERS 2017

13 September 2017


AstraZeneca Investor Science Event at ESMO 2017

8 September 2017


H1 2017 Results

27 July 2017


General Investor presentation

16 June 2017


AstraZeneca Investor Science Event at 2017 ASCO Annual Meeting

5 June 2017


Q1 2017 Results

27 April 2017


Full-Year and Q4 2016 Results

2 February 2017


2016


Second year-end late-stage pipeline investor science webcast

15 December 2016


Year-to-date and Q3 2016 Results

10 November 2016


Investor Relations Benelux roadshow

8 September 2016


ERS Investor science webcast

7 September 2016


DNA Damage Response analyst science event

5 September 2016


H1 2016 Results

28 July 2016


AstraZeneca Investor Science Event at ASCO 2016

7 June 2016


Q1 2016 Results

29 April 2016


Full-Year and Q4 2015 Results

4 February 2016


J.P. Morgan Healthcare Conference 2016

13 January 2016


2015


Majority stake investment in Acerta Pharma

17 December 2015


Late-stage pipeline call

2 December 2015


American College of Rheumatology (ACR) 2015 Investor science conference call

11 November 2015


Acquisition of ZS Pharma

6 November 2015


Year-to-date and Q3 2015 results

5 November 2015


H1 2015 results

30 July 2015


American Society of Clinical Oncology (ASCO) 2015 Investor science event

1 June 2015


AstraZeneca Mölndal 

25 May 2015


First quarter results 2015 

24 April 2015


American College of Cardiology (ACC) 2015 Investor science conference call

16 March 2015


Fourth quarter and full year results 2014

5 February 2015


33rd J.P. Morgan Healthcare Conference

14 January 2015


2014


AstraZeneca Investor Day

18 November 2014


Third quarter and nine months results 2014 

6 November 2014


European Society for Medical Oncology (ESMO) 2014 

28 September 2014


Second quarter and half year results 2014 

31 July 2014


Strategic Transaction with Almirall in Respiratory Disease

30 July 2014


American Society of Clinical Oncology (ASCO) 2014

3 June 2014


American Thoracic Society (ATS) 2014 AstraZeneca Analyst briefing

20 May 2014


AstraZeneca strategy update 

6 May 2014


First quarter results 2014 

24 April 2014


Fourth quarter and full year Results 2013 

6 February 2014


J.P. Morgan Healthcare conference presentation

14 January 2014


2013


Global diabetes alliance analyst call 

19 December 2013


MedImmune R&D Roadshow 

7 November 2013


Third quarter and nine months results 2013 

31 October 2013


Second quarter and half year results 2013 

1 August 2013


American Society of Clinical Oncology (ASCO) 2013 briefing 

1 June 2013


First quarter results 2013

25 April 2013


AstraZeneca Investor Day

21 March 2013


Fourth quarter and full year results 2012

31 January 2013


Partnering for Growth: J.P. Morgan Healthcare Conference

9 January 2013


2012


Fostamatinib analyst briefing

15 November 2012

Fostamatinib analyst briefing video

Play Video


Third quarter and nine months results 2012

25 October 2012


Naloxegol educational presentation

18 October 2012

Naloxegol educational presentation video

Play Video


Second quarter and half year results 2012

26 July 2012


AstraZeneca business update

2 July 2012


R&D Roundtable

14 June 2012


First quarter results 2012

26 April 2012


Fourth quarter and full year results 2011

2 February 2012


30th Annual J.P. Morgan Healthcare Conference

11 January 2012


Upcoming events

Full-Year 2018 Results

Second interim dividend – record date

Second interim dividend – record date

Q1 2019 Results


SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA



Annual reports



Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Josie Afolabi

Other

Craig Marks

Finance, Fixed Income

Henry Wheeler

Oncology

Nick Stone

Respiratory; Renal

Christer Gruvris

Cardiovascular, Metabolism

Jennifer Kretzmann

Retail Investors

US general enquiries